Breathomics can discriminate between anti IgE-treated and non-treated severe asthma adults
Paolo Montuschi (Rome, Italy), Giuseppe Santini, Stefano Di Carlo, Alfredo Benso, Nadia Mores, Paul Brinkman, Salvatore Valente, Paolo Montuschi, Francesco Macagno, Gianfranco Politano, Ariane H. Wagener, Aruna T. Bansal, Hugo H. Knobel, Anton J. Vink, Nicholas Rattray, Marco Santonico, Giorgio Pennazza, Yuanyue Wang, Ildiko Horvath, Ratko Djukanovic, Riccardo Polosa, Stephen J. Fowler, Pascal Chanez, Kian F. Chung, Peter J. Sterk, Paolo Montuschi, U-BIOPRED Study Group
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Session: Phenotyping asthma with biomarkers
Session type: Oral Presentation
Number: 1463
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Paolo Montuschi (Rome, Italy), Giuseppe Santini, Stefano Di Carlo, Alfredo Benso, Nadia Mores, Paul Brinkman, Salvatore Valente, Paolo Montuschi, Francesco Macagno, Gianfranco Politano, Ariane H. Wagener, Aruna T. Bansal, Hugo H. Knobel, Anton J. Vink, Nicholas Rattray, Marco Santonico, Giorgio Pennazza, Yuanyue Wang, Ildiko Horvath, Ratko Djukanovic, Riccardo Polosa, Stephen J. Fowler, Pascal Chanez, Kian F. Chung, Peter J. Sterk, Paolo Montuschi, U-BIOPRED Study Group. Breathomics can discriminate between anti IgE-treated and non-treated severe asthma adults. Eur Respir J 2015; 46: Suppl. 59, 1463
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Prediction of asthma control and treatment changes in obstructive asthmatic children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016
Study of the correlations between FENO and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016
Do severe asthma patients have altered sensitivity to carbon dioxide levels in the control of breathing when compared to healthy individuals? Source: Annual Congress 2013 –Exercise and physiotherapy in non-COPD conditions and in the assessment of healthy subjects Year: 2013
Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test Source: Annual Congress 2013 –Is it really asthma? Year: 2013
Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014
The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014
L-carnitine improves the asthma control in children with moderate persistent asthma Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
ΔFEF25-75 a surrogate marker for mild intermittent asthma: A poor man’s FeNO Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study) Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013
Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013
The effects of oral care on FeNO measurement in asthmatic patients Source: International Congress 2014 – Airway biomarkers Year: 2014
Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
Childhood Severe Asthma: Relationship among asthma control scores, FeNO, spirometry and impulse oscilometry. Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014
The role of allergen immunotherpy in children with mild to moderate asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Repeated breath profiling by eNoses identifies asthma exacerbations and airway eosinophilia Source: International Congress 2014 – Asthma: clinical problems Year: 2014
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013